Enter your email address:

Delivered by FeedBurner

BioNTech says has vaccine pricing benchmark for rich countries for similar volumes

"The price for the U.S. for the first 100 million doses was $19.50 per
dose," said BioNTech's Chief Strategy Officer Ryan Richardson in an
analyst call after the release of third quarter results on Tuesday. He
was referring to a July deal struck by partner Pfizer with the U.S.
government for the supply of the vaccine.



Post a Comment